Literature DB >> 25881561

Mir-17-92 regulates bone marrow homing of plasma cells and production of immunoglobulin G2c.

Shengli Xu1, Xijun Ou2, Jianxin Huo2, Kristen Lim2, Yuhan Huang2, Sheena Chee2, Kong-Peng Lam3.   

Abstract

The polycistronic mir-17-92 cluster, also known as oncomir-1, was previously shown to be essential for early B lymphopoiesis. However, its role in late-stage B-cell differentiation and function remains unexplored. Here we ablate mir-17-92 in mature B cells and demonstrate that mir-17-92 is dispensable for conventional B-cell development in the periphery. Interestingly, mir-17-92-deficiency in B cells leads to enhanced homing of plasma cells to the bone marrow during T-cell-dependent immune response and selectively impairs IgG2c production. Mechanistically, mir-17-92 directly represses the expression of Sphingosine 1-phosphate receptor 1 and transcription factor IKAROS, which are, respectively, important for plasma cell homing and IgG2c production. We further show that deletion of mir-17-92 could reduce IgG2c anti-DNA autoantibody production and hence mitigate immune complex glomerulonephritis in Shp1-deficient mice prone to autoimmunity. Our results identify important roles for mir-17-92 in the regulation of peripheral B-cell function.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25881561     DOI: 10.1038/ncomms7764

Source DB:  PubMed          Journal:  Nat Commun        ISSN: 2041-1723            Impact factor:   14.919


  17 in total

1.  Loss of miR-182 affects B-cell extrafollicular antibody response.

Authors:  Yan-Feng Li; Xijun Ou; Shengli Xu; Zi-Bing Jin; Naoharu Iwai; Kong-Peng Lam
Journal:  Immunology       Date:  2016-03-08       Impact factor: 7.397

Review 2.  miRNAs in B Cell Development and Lymphomagenesis.

Authors:  Maryaline Coffre; Sergei B Koralov
Journal:  Trends Mol Med       Date:  2017-07-07       Impact factor: 11.951

3.  MicroRNA-17-92 is required for T-cell and B-cell pathogenicity in chronic graft-versus-host disease in mice.

Authors:  Yongxia Wu; Steven Schutt; Katelyn Paz; Mengmeng Zhang; Ryan P Flynn; David Bastian; M Hanief Sofi; Hung Nguyen; Min Dai; Chen Liu; Ying-Jun Chang; Bruce R Blazar; Xue-Zhong Yu
Journal:  Blood       Date:  2018-03-12       Impact factor: 22.113

4.  Association Between Serum MicroRNAs and Magnetic Resonance Imaging Measures of Multiple Sclerosis Severity.

Authors:  Keren Regev; Brian C Healy; Fariha Khalid; Anu Paul; Renxin Chu; Shahamat Tauhid; Subhash Tummala; Camilo Diaz-Cruz; Radhika Raheja; Maria A Mazzola; Felipe von Glehn; Pia Kivisakk; Sheena L Dupuy; Gloria Kim; Tanuja Chitnis; Howard L Weiner; Roopali Gandhi; Rohit Bakshi
Journal:  JAMA Neurol       Date:  2017-03-01       Impact factor: 18.302

Review 5.  Noncoding RNAs in B cell responses.

Authors:  Eric J Wigton; K Mark Ansel
Journal:  RNA Biol       Date:  2021-02-15       Impact factor: 4.652

Review 6.  Plasma cell survival: The intrinsic drivers, migratory signals, and extrinsic regulators.

Authors:  Doan C Nguyen; Meixue Duan; Mohammad Ali; Ariel Ley; Ignacio Sanz; F Eun-Hyung Lee
Journal:  Immunol Rev       Date:  2021-08-01       Impact factor: 10.983

7.  Transfection of microRNA Mimics Should Be Used with Caution.

Authors:  Hyun Yong Jin; Alicia Gonzalez-Martin; Ana V Miletic; Maoyi Lai; Sarah Knight; Mohsen Sabouri-Ghomi; Steven R Head; Matthew S Macauley; Robert C Rickert; Changchun Xiao
Journal:  Front Genet       Date:  2015-12-02       Impact factor: 4.599

Review 8.  miRNA-Mediated Control of B Cell Responses in Immunity and SLE.

Authors:  Stephanie L Schell; Ziaur S M Rahman
Journal:  Front Immunol       Date:  2021-05-17       Impact factor: 7.561

Review 9.  Regulation of B Cell Differentiation by Intracellular Membrane-Associated Proteins and microRNAs: Role in the Antibody Response.

Authors:  Zheng Lou; Paolo Casali; Zhenming Xu
Journal:  Front Immunol       Date:  2015-10-26       Impact factor: 7.561

10.  MicroRNA Mechanisms of Action: What have We Learned from Mice?

Authors:  Hyun Yong Jin; Changchun Xiao
Journal:  Front Genet       Date:  2015-11-16       Impact factor: 4.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.